Vol 7, No 5 (October 31, 2018): Chinese Clinical Oncology (Recent Advances in Primary Liver Cancers)

Preface

Current status and evolving treatment for primary liver cancers

Andrew X. Zhu, Thomas A. Aloia

PDF Pages: 47 Full Text (1856) Open Access

Review Article

Hepatocellular carcinoma surgical therapy: perspectives on the current limits to resection

Akhil Chawla, Cristina Ferrone

PDF Pages: 48 Full Text (3538) Open Access

Role of interventional radiology in the management of hepatocellular carcinoma: current status

Daniel J. Holzwanger, David C. Madoff

PDF Pages: 49 Full Text (8511) Open Access

Systemic therapy for hepatocellular carcinoma: beyond sorafenib

Patrick Boland, Jennifer Wu

PDF Pages: 50 Full Text (5899) Open Access

Management of fibrolamellar hepatocellular carcinoma

Vikram A. Chaudhari, Krunal Khobragade, Manish Bhandare, Shailesh V. Shrikhande

PDF Pages: 51 Full Text (18522) Open Access

Intrahepatic cholangiocarcinoma: the AJCC/UICC 8^th edition updates

Andrew J. Lee, Yun Shin Chun

PDF Pages: 52 Full Text (36053) Open Access

Intrahepatic cholangiocarcinoma surgery: the impact of lymphadenectomy

Javier C. Lendoire, Luis Gil, Oscar Imventarza

PDF Pages: 53 Full Text (5953) Open Access

Disclosure:

The focused issue “Recent Advances in Primary Liver Cancers” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Andrew X. Zhu and Thomas A. Aloia served as the unpaid Guest Editors for the focused issue.